Jason Leverone
Net worth: 67 200 $ as of 2026-05-30
Net worth: 67 200 $ as of 2026-05-30
Jason A. Leverone is currently Chief Financial Officer at OnKure Therapeutics, Inc. since 2024.
Former positions include Chief Financial Officer, Secretary & Treasurer at Viridian Therapeutics, Inc. from 2017 to 2021; Head-Finance & Operations at miRagen Therapeutics, Inc. from 2008 to 2012; Finance Director & Controller at Replidyne, Inc. from 2005 to 2009; Controller at CreekPath Systems, Inc. from 2002 to 2005; Principal at Ernst & Young LLP; Principal at KPMG LLP; Chief Financial Officer at OnKure, Inc.; and Audit Manager at Arthur Andersen LLP.
Education includes undergraduate studies at Bryant University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0.04% | 2026-03-31 | 16,000 ( 0.04% ) | 67 200 $ | 2026-05-30 |
| Companies | Position | Start |
|---|
| Companies | Position | End |
|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Director of Finance/CFO | 2021-05-13 |
Replidyne, Inc.
Replidyne, Inc. BiotechnologyHealth Technology Develops and commercializes novel antibiotics to treat infections caused by drug resistant bacteria | Director of Finance/CFO | 2009-01-31 |
CreekPath Systems, Inc.
CreekPath Systems, Inc. Packaged SoftwareTechnology Services Provided storage management solutions | Comptroller/Controller/Auditor | 2005-09-30 |
OnKure, Inc.
OnKure, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing epigenetic therapies for the treatment of cancer | Director of Finance/CFO | - |
Arthur Andersen LLP
Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Comptroller/Controller/Auditor | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 9 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Replidyne, Inc.
Replidyne, Inc. BiotechnologyHealth Technology Develops and commercializes novel antibiotics to treat infections caused by drug resistant bacteria | Health Technology |
miRagen Therapeutics, Inc. /Old/
miRagen Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops microRNA-based therapeutics for cardiovascular and muscle diseases | Health Technology |
OnKure, Inc.
OnKure, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing epigenetic therapies for the treatment of cancer | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
Arthur Andersen LLP
Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
CreekPath Systems, Inc.
CreekPath Systems, Inc. Packaged SoftwareTechnology Services Provided storage management solutions | Technology Services |
Bryant University
Bryant University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viridian Therapeutics, Inc.
Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
Select your edition
All financial news and data tailored to specific country editions